Current Prices from Iterum Therapeutics plc - Ordinary Share

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ITRM	USD	10.06.2025 23:59	1,04 USD	1,01 USD +2,97 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	9,47 %	1,96 %	-20,60 %	-55,37 %	-20,00 %	-95,87 %

Company Profile for Iterum Therapeutics plc - Ordinary Share Share

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Company Data

Name Iterum Therapeutics plc - Ordinary Share

Company Iterum Therapeutics plc

Symbol ITRM

Website https://www.iterumtx.com

Primary Exchange

NASDAQ

ISIN IE000TTOOBX0

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Corey N. Fishman

Market Capitalization 38 Mio

Country Ireland

Currency USD

Employees 0,0 T

Address Fitzwilliam Court, 2 Dublin

IPO Date 2018-05-25

Ticker Symbols

Name	Symbol
NASDAQ	ITRM

More Shares

Investors who Iterum Therapeutics plc - Ordinary Share hold also have the following shares in their portfolio:

LYXOR FTSE MIB DAILY (-1X) INVERSE (BEAR) UCITS ETF - ACC ETF

Revolution Acceleration Acquisition Corp Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog